Capricor Therapeutics, Inc.

CAPR Healthcare Biotechnology

Capricor Therapeutics, Inc.’s revenue for fiscal 2024 (year ended December 2024) was $22.3 million, down 11.5% from fiscal 2023. In the quarter to June 2026, revenue fell 7.92%, EPS fell 22.8% and free cash flow fell 72.9%, each against the same quarter a year earlier.

6.93 0.54 −7.23%
Market cap
$434.3M
P/E
0.0×
Fwd P/E
−13.2×
Dividend yield
—
F-score
4/9
Altman Z
10.32
Beneish M
−2.61
Dividend safety
n/a

A Balance Sheet is a financial statement that provides a snapshot of a company's assets, liabilities, and shareholders' equity at a specific point in time. It follows the formula: Assets = Liabilities + Shareholders' Equity. Key components include current and non-current assets, current and long-term liabilities, and equity. The Balance Sheet helps businesses and investors evaluate financial stability, liquidity, and capital structure. It's essential for assessing the company's ability to meet its obligations and fund future operations.

Jun '26 Mar '26 Dec '25 Sep '25 Older periods
Cash and Short Term Investments
237.93 278.61 318.13 98.57

+8 more quarters

Receivables
— — 0.06 0.06
Total current assets
242.13 283.09 322.94 100.95
Property, Plant, Equpment (Net)
36.35 28.50 18.31 11.07
Long-term assets (Other)
1.65 1.53 1.16 0.49
Total non-current assets
126.61 43.19 33.01 25.49
Total Assets
368.74 326.28 355.95 126.44
Accounts Payable
3.08 3.93 1.65 2.72
Accrued Expenses
16.39 10.53 15.56 9.93
Current Revenue (Deferred)
12.00 12.00 12.00 12.00
Other current liabilities
— 6.34 6.42 3.38
Total current liabilities
32.96 33.64 35.84 28.15
Total non-current liabilities
89.56 13.94 14.32 14.42
Total liabilities
122.52 47.58 50.16 42.57
Additional Paid In Capital
625.88 617.72 610.33 357.69
Common Stock (Net)
0.06 0.06 0.06 0.05
Retained Earnings
(379.55) (338.82) (304.88) (274.71)
Common Equity (Total)
246.22 278.70 305.79 83.87
Shareholders Equity (Total)
246.22 278.70 305.79 83.87
Shareholders Equity and Liabilities (Total)
368.74 326.28 355.95 126.44
Shares (Common)
58.11 57.67 57.37 45.72
Shareholders Equity (Tangible)
246.22 278.70 305.79 83.87
Net Debt
(237.93) (278.61) (318.13) (98.57)

Fold the line items

In millions of $ except per-share values · columns are period end dates